BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 34664248)

  • 1. Migration Stimulating Factor (MSF): Its Role in the Tumour Microenvironment.
    Schor AM; Woolston AM; Kankova K; Harada K; Aljorani LE; Perrier S; Felts PA; Keatch RP; Schor SL
    Adv Exp Med Biol; 2021; 1329():351-397. PubMed ID: 34664248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiogenesis and tumour progression: migration-stimulating factor as a novel target for clinical intervention.
    Schor AM; Schor SL
    Eye (Lond); 2010 Mar; 24(3):450-8. PubMed ID: 20019766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-expression by keratinocytes of migration stimulating factor (MSF) and a functional inhibitor of its bioactivity (MSFI).
    Jones SJ; Florence MM; Ellis IR; Kankova K; Schor SL; Schor AM
    Exp Cell Res; 2007 Dec; 313(20):4145-57. PubMed ID: 17949711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multi-factorial modulation of IGD motogenic potential in MSF (migration stimulating factor).
    Ellis IR; Jones SJ; Staunton D; Vakonakis I; Norman DG; Potts JR; Milner CM; Meenan NA; Raibaud S; Ohea G; Schor AM; Schor SL
    Exp Cell Res; 2010 Sep; 316(15):2465-76. PubMed ID: 20403349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bistable switch in migration stimulating factor expression: regulation by the concerted signalling of transforming growth factor-β1 and the extracellular matrix.
    Schor SL; Ellis IR; Jones SJ; Woolston AM; Schor AM
    Int J Cancer; 2012 May; 130(9):2024-32. PubMed ID: 21630266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Migration-stimulating factor: a genetically truncated onco-fetal fibronectin isoform expressed by carcinoma and tumor-associated stromal cells.
    Schor SL; Ellis IR; Jones SJ; Baillie R; Seneviratne K; Clausen J; Motegi K; Vojtesek B; Kankova K; Furrie E; Sales MJ; Schor AM; Kay RA
    Cancer Res; 2003 Dec; 63(24):8827-36. PubMed ID: 14695199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Migration-stimulating factor (MSF) is over-expressed in non-small cell lung cancer and promotes cell migration and invasion in A549 cells over-expressing MSF.
    Deng X; Ma Q; Zhang B; Jiang H; Zhang Z; Wang Y
    Exp Cell Res; 2013 Oct; 319(17):2545-53. PubMed ID: 23791940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Migration-stimulating factor as a novel biomarker in salivary gland tumours.
    Aljorani LE; Bankfalvi A; Carey FA; Harada K; Ohe G; Jones SJ; Ellis IR; Schor SL; Schor AM
    J Oral Pathol Med; 2011 Nov; 40(10):747-54. PubMed ID: 21481007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Migration-stimulating factor displays HEXXH-dependent catalytic activity important for promoting tumor cell migration.
    Houard X; Germain S; Gervais M; Michaud A; van den Brûle F; Foidart JM; Noël A; Monnot C; Corvol P
    Int J Cancer; 2005 Sep; 116(3):378-84. PubMed ID: 15800942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenotypic and genetic alterations in mammary stroma: implications for tumour progression.
    Schor SL; Schor AM
    Breast Cancer Res; 2001; 3(6):373-9. PubMed ID: 11737888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic remodeling of the tumor microenvironment: migration stimulating factor (MSF) reprograms myofibroblasts toward lactate production, fueling anabolic tumor growth.
    Carito V; Bonuccelli G; Martinez-Outschoorn UE; Whitaker-Menezes D; Caroleo MC; Cione E; Howell A; Pestell RG; Lisanti MP; Sotgia F
    Cell Cycle; 2012 Sep; 11(18):3403-14. PubMed ID: 22918248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3D-3-culture: A tool to unveil macrophage plasticity in the tumour microenvironment.
    Rebelo SP; Pinto C; Martins TR; Harrer N; Estrada MF; Loza-Alvarez P; Cabeçadas J; Alves PM; Gualda EJ; Sommergruber W; Brito C
    Biomaterials; 2018 May; 163():185-197. PubMed ID: 29477032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-conditioned macrophages secrete migration-stimulating factor: a new marker for M2-polarization, influencing tumor cell motility.
    Solinas G; Schiarea S; Liguori M; Fabbri M; Pesce S; Zammataro L; Pasqualini F; Nebuloni M; Chiabrando C; Mantovani A; Allavena P
    J Immunol; 2010 Jul; 185(1):642-52. PubMed ID: 20530259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracellular vesicles derived from cancer-associated fibroblasts induce the migration and invasion of oral squamous cell carcinoma.
    Dourado MR; Korvala J; Åström P; De Oliveira CE; Cervigne NK; Mofatto LS; Campanella Bastos D; Pereira Messetti AC; Graner E; Paes Leme AF; Coletta RD; Salo T
    J Extracell Vesicles; 2019; 8(1):1578525. PubMed ID: 30788085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Migration Stimulating Factor (MSF) promotes fibroblast migration by inhibiting AKT.
    Ellis IR; Jones SJ; Lindsay Y; Ohe G; Schor AM; Schor SL; Leslie NR
    Cell Signal; 2010 Nov; 22(11):1655-9. PubMed ID: 20600851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The expression of migration stimulating factor, a potent oncofetal cytokine, is uniquely controlled by 3'-untranslated region-dependent nuclear sequestration of its precursor messenger RNA.
    Kay RA; Ellis IR; Jones SJ; Perrier S; Florence MM; Schor AM; Schor SL
    Cancer Res; 2005 Dec; 65(23):10742-9. PubMed ID: 16322219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogeneity amongst fibroblasts in the production of migration stimulating factor (MSF): implications for cancer pathogenesis.
    Schor SL; Grey AM; Picardo M; Schor AM; Howell A; Ellis I; Rushton G
    EXS; 1991; 59():127-46. PubMed ID: 1833226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Migration stimulating factor (MSF): its structure, mode of action and possible function in health and disease.
    Schor SL; Grey AM; Ellis I; Schor AM; Coles B; Murphy R
    Symp Soc Exp Biol; 1993; 47():235-51. PubMed ID: 8165568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of migration stimulating activity in wound fluid.
    Picardo M; Grey AM; McGurk M; Ellis I; Schor SL
    Exp Mol Pathol; 1992 Aug; 57(1):8-21. PubMed ID: 1397194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of vascular endothelial growth factor (VEGF) and its two receptors (VEGF-R1-Flt1 and VEGF-R2-Flk1/KDR) in non-small cell lung carcinomas (NSCLCs): correlation with angiogenesis and survival.
    Decaussin M; Sartelet H; Robert C; Moro D; Claraz C; Brambilla C; Brambilla E
    J Pathol; 1999 Aug; 188(4):369-77. PubMed ID: 10440746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.